Skip to content
Portage Biotech
Portage BiotechPortage Biotech
  • about us
    • overview
    • leadership
  • our pipeline
    • iNKT platform
    • adenosine platform
    • other programs in development
  • investors
    • overview
    • stock information
    • news releases
    • investor calendar
    • presentations & publications
    • sec filings
    • financial & regulatory reports
    • corporate governance
    • investor faqs
  • join our team
  • contact
  • about us
    • overview
    • leadership
  • our pipeline
    • iNKT platform
    • adenosine platform
    • other programs in development
  • investors
    • overview
    • stock information
    • news releases
    • investor calendar
    • presentations & publications
    • sec filings
    • financial & regulatory reports
    • corporate governance
    • investor faqs
  • join our team
  • contact

Daily Archives: December 6, 2019

Portage Biotech Inc. (CSE: PBT.U, OTC Markets: PTGEF) (“Portage” or the “Company”) is pleased to announce that it has been granted an extension by the Canadian Securities Exchange (the “CSE”) to remedy its default under CSE listing rules.

Press ReleaseBy Portage Biotech, IncDecember 6, 2019
...
Copyright © All rights reserved Portage Biotech, Inc

terms of use   privacy policy   disclaimer

Go to Top